Summary

The South & Central America vascular closure device market was valued at US$ 86.24 million in 2022 and is expected to reach US$ 144.86 million by 2030; it is estimated to record a CAGR of 6.7% from 2022 to 2030.

Increasing Prevalence of Cardiovascular Diseases Drives South & Central America Vascular Closure Device Market

Cardiovascular diseases such as atherosclerosis, angina pectoris, and acute myocardial infarction are the major causes of mortality in the world. As per data provided by the World Health Organization (WHO), cardiovascular diseases cause nearly 17.9 million deaths every year, which makes it a leading cause of mortality among all noncommunicable diseases, followed by cancer, chronic respiratory diseases, and diabetes (including deaths associated with renal disorders). According to the World Heart Federation, high cholesterol causes 4.4 million deaths yearly, and 24% of cardiovascular-related deaths are associated with high low-density lipoprotein (LDL) levels. Vascular closure devices (VCDs) offer a new way to enhance patients' comfort and ambulation after invasive cardiovascular treatments via femoral arterial access. Vascular closure devices are used in different therapeutic approaches to provide easy, quick, and reliable hemostasis. In the US, femoral arterial access is the most often used vascular access technique for percutaneous coronary intervention (PCI) and coronary angiography. Nevertheless, there has been an increase in traction toward cardiac catheterization and percutaneous coronary intervention (PCI) via radial access in recent years. Several femoral artery closure devices have been developed to shorten vascular closure times, with variable rates of vascular complications observed in clinical trials. Vascular closure devices (VCDs) have emerged as an effective alternative to traditional mechanical compression procedures performed after cardiac catheterization. VCDs reduce the time of hospital stays, speed up patient mobilization and shorten the time needed to achieve hemostasis. Thus, the South & Central America South & Central America Vascular Closure Device Market is growing notably with the increasing prevalence of cardiovascular diseases.

South & Central America Vascular Closure Device Market Overview

Brazil has a proactive medical device industry, and it is the largest of all Latin American countries. According to the International Trade Administration (US Department of Commerce), the medical device industry in Brazil relies mainly on the US, China, and Germany. In 2021, the country reported an increase of 7.3% in the imports of medical devices, reaching the value of US$ 6.2 billion. Per the "Cardiovascular Care in Brazil: Current Status, Challenges, and Opportunities" study published in August 2022 in AHA Journals, the prevalence of CVDs in Brazil has increased by 26.8% over the past three decades. Moreover, in 2019, the age-standardized rate (ASR) of CVD prevalence was 5,454, and incidence was 475 per 100,000 inhabitants. Thus, the increasing cardiovascular disease incidence provides lucrative opportunities for the vascular closure devices market in Brazil.

South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Vascular Closure Device Market Segmentation

The South & Central America vascular closure device market is segmented based on product type, access, procedure, end user, and country.

Based on product type, the South & Central America vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.

By access, the South & Central America vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.

By procedure, the South & Central America vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.

In terms of end use, the South & Central America vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.

Based on country, the South & Central America vascular closure device market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America vascular closure device market in 2022.

Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, Haemonetics Corp, Medtronic Plc, and Teleflex Inc are some of the leading companies operating in the South & Central America vascular closure device market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Vascular Closure Device Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Cardiovascular Diseases
4.1.2 Burgeoning Demand for Minimally Invasive Devices
4.2 Market Restraints
4.2.1 Risk of Infection Related to Vascular Closure Devices
4.3 Market Opportunities
4.3.1 Untapped Potential of Emerging Economies
4.4 Future Trends
4.4.1 Strategic Activities by Manufacturers
4.5 Impact Analysis:
5. Vascular Closure Device Market - South & Central America Market Analysis
5.1 South & Central America Vascular Closure Device Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 - by Product Type
6.1 Overview
6.2 South & Central America Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
6.3 Active Approximators
6.3.1 Overview
6.3.2 Active Approximators: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Active Approximators: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Passive Approximators
6.4.1 Overview
6.4.2 Passive Approximators: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Passive Approximators: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.5 External Hemostatic Devices
6.5.1 Overview
6.5.2 External Hemostatic Devices: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 - by Access
7.1 Overview
7.2 South & Central America Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
7.3 Femoral Access
7.3.1 Overview
7.3.2 Femoral Access: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Radial Access
7.4.1 Overview
7.4.2 Radial Access: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 - by Procedure
8.1 Overview
8.2 South & Central America Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
8.3 Interventional Cardiology
8.3.1 Overview
8.3.2 Interventional Cardiology: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Interventional Radiology
8.4.1 Overview
8.4.2 Interventional Radiology: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Endovascular Surgical
8.5.1 Overview
8.5.2 Endovascular Surgical: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 - by End Users
9.1 Overview
9.2 South & Central America Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Center
9.4.1 Overview
9.4.2 Ambulatory Surgical Center: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Vascular Closure Device Market - Country Analysis
10.1.1.1 South & Central America Vascular Closure Device Market by Country
10.1.1.2 Brazil
10.1.1.2.1 Overview
10.1.1.2.2 Brazil: South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Brazil: South & Central America Vascular Closure Device Market, by Product Type
10.1.1.2.3.1 Brazil: South & Central America Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.2.3.2 Brazil: South & Central America Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.2.4 Brazil South & Central America Vascular Closure Device Market, by Access
10.1.1.2.5 Brazil: South & Central America Vascular Closure Device Market, by Procedure
10.1.1.2.6 Brazil: South & Central America Vascular Closure Device Market, by End Users
10.1.1.3 Argentina
10.1.1.3.1 Overview
10.1.1.3.2 Argentina: South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Argentina: South & Central America Vascular Closure Device Market, by Product Type
10.1.1.3.3.1 Argentina: South & Central America Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.3.3.2 Argentina: South & Central America Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.3.4 Argentina: South & Central America Vascular Closure Device Market, by Access
10.1.1.3.5 Argentina: South & Central America Vascular Closure Device Market, by Procedure
10.1.1.3.6 Argentina: South & Central America Vascular Closure Device Market, by End Users
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Overview
10.1.1.4.2 Rest of South & Central America: South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Product Type
10.1.1.4.3.1 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.4.3.2 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.4.4 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Access
10.1.1.4.5 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Procedure
10.1.1.4.6 Rest of South & Central America: South & Central America Vascular Closure Device Market, by End Users
11. Vascular Closure Device Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Vascular Closure Devices Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Cordis Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Haemonetics Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Becton Dickinson and Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cardinal Health Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medtronic Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Teleflex Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms